Review Series

Introduction to the Review Series. Chronic myeloid leukemia in 2026 (194 Online Views)

Jerald Radich

https://doi.org/10.3324/haematol.2025.288338

Prognostic factors in chronic myeloid leukemia: at diagnosis and for treatment-free remission (1085 Online Views)

Delphine Rea

https://doi.org/10.3324/haematol.2025.287756

Is there a best frontline therapy in chronic myeloid leukemia? (1697 Online Views)

Akriti G. Jain, Mark Dalgetty, Jorge E. Cortes

https://doi.org/10.3324/haematol.2025.287813

Understanding drug resistance in chronic myeloid leukemia through the lens of leukemic stem cell states: insights from single-cell analyses (786 Online Views)

Vaidehi Krishnan, Pavithra Shyamsunder, Tiong S. Ong

https://doi.org/10.3324/haematol.2025.287767

Intrinsic cellular resistance to BCR::ABL1 inhibitors (745 Online Views)

Nataly Cruz-Rodriguez, Yulieth Torres-Llanos, Michael W. Deininger

https://doi.org/10.3324/haematol.2025.287814

Management of chronic myeloid leukemia with tyrosine kinase inhibitors: adverse events, toxicities and therapy dosing (703 Online Views)

Vivian G. Oehler, Ellin Berman, Ivan J. Huang

https://doi.org/10.3324/haematol.2025.288334

Improving quality of life for patients with chronic myeloid leukemia through supportive care, low-dose therapy, switching, and treatment-free remission (1040 Online Views)

Kathryn E. Flynn, Ehab Atallah

https://doi.org/10.3324/haematol.2025.287766

Introduction to the Review Series. Clonal hematopoiesis review series – from biology to clinical management (2194 Online Views)

Anastasija A. Piric, Aaron D. Schimmer

https://doi.org/10.3324/haematol.2025.288295

Clonal hematopoiesis and its progression to myeloid neoplasms: insights into risk, biology, and therapeutic strategies (3079 Online Views)

J. Scott Beeler, Matthew J. Walter, Kelly L. Bolton

https://doi.org/10.3324/haematol.2025.287488

What’s hidden in plain sight? Impact of clonal hematopoiesis on the risk and progression of nonhematologic cancers (2832 Online Views)

José C. Martínez, Catherine C. Coombs

https://doi.org/10.3324/haematol.2025.287424

Novel and emerging therapeutic strategies for clonal hematopoiesis (2726 Online Views)

Mohsen Hosseini, Steven M. Chan

https://doi.org/10.3324/haematol.2025.287443

Clonal hematopoiesis driver mutations: molecular mechanisms and clinical implications - inclusive fitness of pre-leukemic hematopoietic stem and progenitor cells through pro-inflammatory features of their progeny (1802 Online Views)

Tal Bacharach, Adrian Duek, Liran I. Shlush

https://doi.org/10.3324/haematol.2025.287480

Clinical decisions in clonal hematopoiesis: a contemporary review for clinicians (3913 Online Views)

Robert J. Vanner, Andy G.X. Zeng, Raymond H. Kim, Steven Chan, Aniket Bankar

https://doi.org/10.3324/haematol.2025.287422

Introduction to the Review Series. A century after Erik von Willebrand (2360 Online Views)

Pier Mannuccio Mannucci, Francesco Rodeghiero

https://doi.org/10.3324/haematol.2024.286060

Structure and multiple functions of von Willebrand factor (5861 Online Views)

Sandra L. Haberichter, James S. O’Donnell

https://doi.org/10.3324/haematol.2024.286029

Von Willebrand disease: classification and epidemiology (5940 Online Views)

Giancarlo Castaman, Augusto Bramante Federici

https://doi.org/10.3324/haematol.2024.286058

Clinical and laboratory diagnosis of von Willebrand disease (4481 Online Views)

Alberto Tosetto, Jeroen Eikenboom

https://doi.org/10.3324/haematol.2024.286011

Molecular genetic testing in von Willebrand disease: past, present, and beyond (2295 Online Views)

Omid Seidizadeh, David Lillicrap

https://doi.org/10.3324/haematol.2024.286014

Historical, current and future treatments for von Willebrand disease (3769 Online Views)

Caterina Casari, Frank W.G. Leebeek, Flora Peyvandi

https://doi.org/10.3324/haematol.2024.286037

Gynecologic and obstetric management of girls and women with von Willebrand disease (2984 Online Views)

Rezan Abdul-Kadir, Margaret V. Ragni

https://doi.org/10.3324/haematol.2024.286059

Introduction to the Review Series. Looking back and to the future: the Histiocyte Society blueprint for research in histiocytic disorders (2398 Online Views)

Gaurav Goyal, Vasanta Nanduri

https://doi.org/10.3324/haematol.2024.286481

Histiocyte Society blueprint for hemophagocytic lymphohistiocytosis research: deciphering underlying disease mechanisms to optimize diagnosis and therapy (7902 Online Views)

Lauren K. Meyer, Jerry C. Lee, Joseph M. Rocco, Kim E. Nichols

https://doi.org/10.3324/haematol.2024.286477

Histiocyte Society blueprint for Langerhans cell histiocytosis research: from cell-of-origin to a more comprehensive cure (5094 Online Views)

Francesco Pegoraro, Maria Kondyli, Zachary D. Prudowsky, Astrid G.S. van Halteren

https://doi.org/10.3324/haematol.2024.286478

Histiocyte Society blueprint for non-Langerhans cell histiocytosis research: unraveling complex diseases through collaboration (4318 Online Views)

Oshrat Hershkovitz-Rokah, Jithma P. Abeykoon, Aishwarya Ravindran, Gaurav Goyal

https://doi.org/10.3324/haematol.2024.286479

Pediatric acute leukemias and myelodysplastic syndromes, progress and challenges: introduction to a review series (2524 Online Views)

Shai Izraeli

https://doi.org/10.3324/haematol.2024.286783

Acute therapy-related toxicities in pediatric acute lymphoblastic leukemia (5763 Online Views)

Shlomit Barzilai Birenboim, Ron Rabinowicz

https://doi.org/10.3324/haematol.2024.285702

Relapsed childhood T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma (11677 Online Views)

Andrew D. Hughes, Petri Pölönen, David T. Teachey

https://doi.org/10.3324/haematol.2024.285643

KMT2A-rearranged acute lymphoblastic leukemia in infants: current progress and challenges (8550 Online Views)

Janine Stutterheim, Inge M. van der Sluis, Kirsten S. Vrenken, Rob Pieters, Ronald W. Stam

https://doi.org/10.3324/haematol.2024.285642

Novel classification system and high-risk categories of pediatric acute myeloid leukemia (8336 Online Views)

Masayuki Umeda, Yen-Chun Liu, Seth E. Karol, Jeffery M. Klco

https://doi.org/10.3324/haematol.2024.285644

Germline and somatic genetic landscape of pediatric myelodysplastic syndromes (8234 Online Views)

Lili Kotmayer, Alyssa L. Kennedy, Marcin W. Wlodarski

https://doi.org/10.3324/haematol.2024.285700

Prevention, diagnosis and management of myeloproliferative neoplasms: an introduction to a review series (5236 Online Views)

Yin Yuan, Steven W. Lane

https://doi.org/10.3324/haematol.2024.285414

Prevention and treatment of transformation of myeloproliferative neoplasms to acute myeloid leukemia (9753 Online Views)

Anand A. Patel, Raajit K. Rampal

https://doi.org/10.3324/haematol.2023.283950

Evolution of myeloproliferative neoplasms from normal blood stem cells (5658 Online Views)

Sahand Hormoz, Vijay G. Sankaran, Ann Mullally

https://doi.org/10.3324/haematol.2023.283951

New approaches to standard of care in early-phase myeloproliferative neoplasms: can interferon-α alter the natural history of the disease? (8147 Online Views)

Florence Pasquier, Jean Pegliasco, Jean-Edouard Martin, Severine Marti, Isabelle Plo

https://doi.org/10.3324/haematol.2023.283958

Pathogenesis and management of high molecular risk myeloproliferative neoplasms (7976 Online Views)

Victoria Y. Ling, Florian H. Heidel, Megan J. Bywater

https://doi.org/10.3324/haematol.2023.283987

Introduction to the Review Series on Myelodysplasia (6217 Online Views)

Moshe Mittelman

https://doi.org/10.3324/haematol.2023.284948

Pathogenesis and inflammaging in myelodysplastic syndrome (11584 Online Views)

Matthew T. Villaume, Michael R. Savona

https://doi.org/10.3324/haematol.2023.284944

Diagnosis of myelodysplastic syndromes: the classic and the novel (21045 Online Views)

Howard S. Oster, Arjan A. van de Loosdrecht, Moshe Mittelman

https://doi.org/10.3324/haematol.2023.284937

Genome sequencing in the management of myelodysplastic syndromes and related disorders (8069 Online Views)

Mario Cazzola, Luca Malcovati

https://doi.org/10.3324/haematol.2023.284947

Treatment of lower-risk myelodysplastic syndromes (14968 Online Views)

Almuth Maria Anni Merz, Uwe Platzbecker

https://doi.org/10.3324/haematol.2023.284945

Treatment of high-risk myelodysplastic syndromes (19829 Online Views)

Nicolaus Kröger

https://doi.org/10.3324/haematol.2023.284946

Introduction to the Review Series on venous thromboembolism: emerging issues in pathophysiology and management (3323 Online Views)

Paolo Prandoni

https://doi.org/10.3324/haematol.2024.286591

Multimorbidity, comorbidity, frailty, and venous thromboembolism (6648 Online Views)

Bengt Zöller, Jean M. Connors

https://doi.org/10.3324/haematol.2023.284579

Minor trauma and venous thromboembolism: the threshold for antithrombotic prophylaxis (5456 Online Views)

Alexandre Tran, Pamela L. Lutsey, Marc Carrier

https://doi.org/10.3324/haematol.2023.284612

Targeted anti-cancer agents and risk of venous thromboembolism (5191 Online Views)

Melina Verso, Florian Moik, Mara Graziani, Alexander T. Cohen

https://doi.org/10.3324/haematol.2023.284778

Introduction. Immunotherapy for childhood malignancies: the future is now (3500 Online Views)

Franco Locatelli

https://doi.org/10.3324/haematol.2023.284553

Chimeric antigen receptor T-cell therapy in childhood acute myeloid leukemia: how far are we from a clinical application? (6781 Online Views)

Swati Naik, M. Paulina Velasquez, Stephen Gottschalk

https://doi.org/10.3324/haematol.2023.283817

Bispecific T-cell engagers in childhood B-acute lymphoblastic leukemia (6114 Online Views)

Kaylyn Utley Lyons, Lia Gore

https://doi.org/10.3324/haematol.2023.283818

Chimeric antigen receptor T-cell therapy for T-cell acute lymphoblastic leukemia (10482 Online Views)

Bernice L.Z. Oh, Natasha Vinanica, Desmond M.H. Wong, Dario Campana

https://doi.org/10.3324/haematol.2023.283848

Allogeneic chimeric antigen receptor T cells for children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (6110 Online Views)

Franco Locatelli, Francesca del Bufalo, Concetta Quintarelli

https://doi.org/10.3324/haematol.2023.284604

Naked antibodies and antibody-drug conjugates: targeted therapy for childhood acute lymphoblastic leukemia (8239 Online Views)

Erica Brivio, Francisco Bautista, C. Michel Zwaan

https://doi.org/10.3324/haematol.2023.283815

Introduction to the peripheral T-cell lymphoma review series: advances in molecular characterization, classification refinement and treatment optimization (10948 Online Views)

Kerry J. Savage, Laurence de Leval

https://doi.org/10.3324/haematol.2023.282719

Past, present and future therapeutic approaches in nodal peripheral T-cell lymphomas (8786 Online Views)

Henry S. Ngu, Kerry J. Savage

https://doi.org/10.3324/haematol.2021.280275

Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions (10083 Online Views)

Bettina Bisig, Kerry J. Savage, Laurence de Leval

https://doi.org/10.3324/haematol.2023.282716

Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas (6520 Online Views)

Robert Stuver, Zachary D. Epstein-Peterson, Steven M. Horwitz

https://doi.org/10.3324/haematol.2023.282717

Biology and genetics of extranodal mature T-cell and NK-cell lymphomas and lymphoproliferative disorders (5612 Online Views)

Natasha E. Lewis, Ting Zhou, Ahmet Dogan

https://doi.org/10.3324/haematol.2023.282718

Acute myeloid leukemia: introduction to a series highlighting progress and ongoing challenges (6611 Online Views)

Richard F. Schlenk

https://doi.org/10.3324/haematol.2022.280803

New drugs before, during, and after hematopoietic stem cell transplantation for patients with acute myeloid leukemia (13833 Online Views)

Razan Mohty, Rama El Hamed, Eolia Brissot, Ali Bazarbachi, Mohamad Mohty

https://doi.org/10.3324/haematol.2022.280798

Update on current treatments for adult acute myeloid leukemia: to treat acute myeloid leukemia intensively or non-intensively? That is the question (15599 Online Views)

Sonia Jaramillo, Richard F. Schlenk

https://doi.org/10.3324/haematol.2022.280802

Leukemic stem cells and therapy resistance in acute myeloid leukemia (35916 Online Views)

Patrick Stelmach, Andreas Trumpp

https://doi.org/10.3324/haematol.2022.280800

The clinical impact of the molecular landscape of acute myeloid leukemia (28526 Online Views)

Sabine Kayser, Mark J. Levis

https://doi.org/10.3324/haematol.2022.280801

Introduction to the Series on Measurable Residual Disease (3595 Online Views)

Jerry Radich

https://doi.org/10.3324/haematol.2022.281079

Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients (46037 Online Views)

Caner Saygin, Joseph Cannova, Wendy Stock, Lori Muffly

https://doi.org/10.3324/haematol.2022.280638

Measurable residual disease in chronic myeloid leukemia (7607 Online Views)

Susan Branford, Jane F. Apperley

https://doi.org/10.3324/haematol.2022.281493

The present and future of measurable residual disease testing in acute myeloid leukemia (15241 Online Views)

James S. Blachly, Roland B. Walter, Christopher S. Hourigan

https://doi.org/10.3324/haematol.2022.282034

Introduction to a review series on the treatment of thrombocytopenic disorders: something old, something new (4435 Online Views)

Francesco Rodeghiero

https://doi.org/10.3324/haematol.2022.280920

Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies (43849 Online Views)

David J. Kuter

https://doi.org/10.3324/haematol.2021.279512

Treatment of drug-induced immune thrombocytopenias (23426 Online Views)

Irene Marini, Gunalp Uzun, Kinan Jamal, Tamam Bakchoul

https://doi.org/10.3324/haematol.2021.279484

Treatment of inherited thrombocytopenias (8407 Online Views)

Carlo L. Balduini

https://doi.org/10.3324/haematol.2022.280856

Indolent lymphomas: introduction to a series highlighting progress and ongoing challenges (5523 Online Views)

Sonali M. Smith, Gilles Salles

https://doi.org/10.3324/haematol.2021.280218

Time for an individualized approach to first-line management of follicular lymphoma (18106 Online Views)

Guillaume Cartron, Judith Trotman

https://doi.org/10.3324/haematol.2021.278766

Prospects in the management of patients with follicular lymphoma beyond first-line therapy (21599 Online Views)

David Qualls, Gilles Salles

https://doi.org/10.3324/haematol.2021.278717

Marginal zone lymphoma: present status and future perspectives (52347 Online Views)

Chan Y. Cheah, Emanuele Zucca, Davide Rossi, Thomas M. Habermann

https://doi.org/10.3324/haematol.2021.278755

July 2026: Chronic Myeloid Leukemia

May 2026: Clonal hematopoiesis

January 2026: Celebrating the Centenary of von Willebrand Disease

November 2025: Histiocytic Disorders

September 2025: Pediatric acute leukemias and myelodysplastic syndromes

April 2025: Myeloproliferative Neoplasms

February 2025: Myelodysplasia

December 2024: Venous Thromboembolism

June 2024: Immunotherapy for childhood malignancies

December 2023: Peripheral T-Cell Lymphomas

February 2023: Acute Myeloid Leukemia

December 2022: Measurable Residual Disease

June 2022: Treatment of thrombocytopenias

January 2022: Indolent lymphomas

What about you?

Navigate

For Authors

For Reviewers

For Advertisers

Education

Privacy

More